Ingevity Corp
For the period ended Dec 31, 2024. Filed Feb 19, 2025.
View on SEC.govAbout this filing
A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.
FY2024 · Filed Feb 19, 2025
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Property, Plant, and Equipment, net
Note 7: Property, Plant, and Equipment, net
| December 31, | ||
|---|---|---|
| In millions | 2024 | 2023 |
| Machinery and equipment | $1,296.4 | $1,244.6 |
| Buildings and leasehold improvements | 224.3 | 217.4 |
| Land and land improvements | 26.2 | 26.3 |
| Construction in progress | 68.9 | 92.8 |
| Total cost | $1,615.8 | $1,581.1 |
| Less: accumulated depreciation (1) | (956.9) | (818.9) |
| Property, plant, and equipment, net (2) | $658.9 | $762.2 |
(1) As a result of the Performance Chemicals repositioning, as further described in Note 15, we accelerated the depreciation of certain property, plant, and equipment assets in 2024 and 2023. This resulted in $92.6 million and $46.3 million of additional expense for the years ended December 31, 2024 and 2023, respectively, which is included in Restructuring and other (income) charges, net within the consolidated statement of operations.
Index
(2) Includes finance leases related to machinery and equipment of $93.7 million and $94.2 million, and net carrying value of $20.3 million and $22.7 million; buildings and leasehold improvements of $39.2 million and $39.2 million, and net carrying value of $29.9 million and $32.3 million, respectively. Amortization expense associated with these finance leases is included within depreciation expense. The payments remaining under these finance lease obligations are included within Note 13.
Depreciation expense, excluding accelerated depreciation included in Restructuring and other (income) charges, net, was $71.6 million, $81.5 million, and $70.9 million for the years ended December 31, 2024, 2023, and 2022, respectively.
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.